Alira Health

Alira Health

2022 Recap: Your Favorite Alira Health Publications

In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance on the industry trends. As 2022 ends, let’s look at our 10 most popular publications.

Reports and White Papers

The 2022 MedTech Contract Manufacturing Report

2021 was a remarkable year for the global medical device industry—just as healthcare systems were learning to cope with the enduring effects of the COVID-19 pandemic, ramping up procedures and product demand, device manufacturers were hit by the most severe supply chain crisis in decades. Our report investigates how trends and the current environment will impact the industry. | Download the report

A Robotic-Assisted Surgery (RAS) Review: Clinical Landscape, Commercial Arena, and Future Outlook

One of our most popular reports for two years running! Created in collaboration with Hunniwell Ventures and MassMEDIC, this report examines adoption dynamics today—technologies, business models, stakeholders, decision criteria, funding and more—as well as what’s changing to drive this fast-growing market. | Download the report

Relative Weight of the Variables Evaluated Through the Therapeutic Positioning Reports in the Pricing and Reimbursement of Oncological and Oncohematology Medicines in Spain

Decisions for new drugs in Spain are based on regulation LGURM RD 1/2015 and the clinical evidence, economic value, and positioning of each new drug in relation to the Therapeutic Positioning Report (TPR). This white paper explores how despite this clear pricing & reimbursement (P&R) framework, the weight of each criterion on P&R decisions is not transparent. Only available in Spanish | Download the white paper



How—and Why—the Role of Clinical Data Manager is Changing

Clinical trials are becoming increasingly complex—new data collection technologies, data visualization tools, and the COVID-19 pandemic have all impacted the way trials are conducted. We spoke to Monica Pimazzoni, Director of Clinical Data Management of CROS NT, an Alira Health company, about how the role of data manager continues to evolve. | Read the article

Patient Advocacy and Digital Transformation: Why and How

Patient stories are powerful advocacy tools and combined with advanced technology helps advocacy groups provide better insights to drive improved care for patients and their caregivers. This three-part, on-demand training explores how technology can better catalyze patient outcomes. | Start the training

Successful Patient Advisory Boards: What Sponsors Need to Know

Patient Advisory Boards (PABs) allow sponsor companies to capture actionable patient feedback that can guide all stages of development and project prioritization, as well as improve research outcomes and de-risk early science. With patient engagement increasingly essential for successful commercialization, sponsors can leverage PABs to address many lifecycle challenges at once. | Read the article



Webinars and Expert Panels

Regulatory Strategy for Registering Rare Disease Products in the EU

Approximately 30 million people living in the EU suffer from a rare disease and rely on the Orphan Drug Regulation 141/2000 to bring appropriate medications to market. In 2021, the European Commission proposed amendments to the regulation. We explore what the current regulations and potential changes mean for orphan drug developers. | Watch the replay

Exclusive MedTech Series: Expanding Beyond APAC

Created in partnership with APACMed, this free, on-demand webinar series discusses the strategies, challenges, and best practices of entering new markets and scaling beyond the Asia Pacific for MedTech companies. | Watch the replay

Panel: Patient Advisory Boards in Clinical Research: Why and How

Watch the recording of this unique roundtable discussion around best practices for planning, setting up, and managing your Patient Advisory Board (PAB) alongside the leading industry experts. | Watch the replay

Related news

Reports May 20, 2024
Innovative Payment Schemes for Medtech in England, Germany, and France
This overview offers high-level details on the innovative payment schemes in England, Germany, and France.
Case Studies May 14, 2024
Medtech Company Creates an Early Go-to-Market Strategy for Its Breakthrough IVD Solution
The client needed an early go-to-market strategy for their IVD solution to prepare for product development and launch in key European countries and the US.
IVDR Medical Devices MedTech
Case Studies May 8, 2024
Mid-Size Medtech Company with a Borderline Product Defines Strategy for EU Launch
Medtech company sought support in developing a regulatory strategy for the EU launch of their product with an aggressive timeline to launch.
Medical Devices MedTech Regulatory
Reports May 8, 2024
Value-Based Procurement in Australia
This white paper discusses why value-based healthcare and procurement are solutions in a robust healthcare system and identifies the medical technology sector as a collaborative partner(...)
MedTech Value-Based Contracts
Case Studies April 30, 2024
Medtech Company Leverages Bayesian Clinical Trial Design to Address FDA Feedback
A global medtech company needed help to address FDA feedback on their implant design that included a comparator and clearly demonstrated the safety and performance of this new device.
Clinical Trials Complex Innovative Design MedTech
Events April 30, 2024
The MedTech Forum 2024
We are thrilled to announce that we will exhibit and speak at The MedTech Forum 2024.
MedTech Regulatory
News April 29, 2024
Alira Health Advises Trill Impact Entering a Strategic Alliance with TT medic
We are pleased to have been a Commercial Due Diligence advisor for Trill Impact, a pioneering Impact House with around EUR 1.2 billion in assets under management, joining forces with(...)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.